Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaro Yano

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Optics Express|June 11, 2024
Omnidirectional mid-air image system using micro-mirror array platesYutaro Yano, Naoya Koizumi
Oncology Reports|September 18, 2004
Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptideKaori Okugawa, Tsuyoshi Itoh, Ichiro Kawashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Immunogenic reactivity of CTLs induced by electrofusion cells of human dendritic cells and gastric cancer cells]Kenichirou Imura, Takashi Hayashi, Yutaro Yano, et al.
Oncology Reports|June 21, 2006
A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitroYutaro Yano, Yuji Ueda, Tsuyohi Itoh, et al.
International Journal of Oncology|May 11, 2006
Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacityKei Naito, Yuji Ueda, Tsuyoshi Itoh, et al.
International Journal of Oncology|July 26, 2006
Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion techniqueKenichiro Imura, Yuji Ueda, Takashi Hayashi, et al.
International Journal of Oncology|March 11, 2004
Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomasYuji Ueda, Tsuyoshi Itoh, Ikuei Nukaya, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Optics Express|June 11, 2024
Omnidirectional mid-air image system using micro-mirror array platesYutaro Yano, Naoya Koizumi
Oncology Reports|September 18, 2004
Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptideKaori Okugawa, Tsuyoshi Itoh, Ichiro Kawashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Immunogenic reactivity of CTLs induced by electrofusion cells of human dendritic cells and gastric cancer cells]Kenichirou Imura, Takashi Hayashi, Yutaro Yano, et al.
Oncology Reports|June 21, 2006
A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitroYutaro Yano, Yuji Ueda, Tsuyohi Itoh, et al.
International Journal of Oncology|May 11, 2006
Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacityKei Naito, Yuji Ueda, Tsuyoshi Itoh, et al.
International Journal of Oncology|July 26, 2006
Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion techniqueKenichiro Imura, Yuji Ueda, Takashi Hayashi, et al.
International Journal of Oncology|March 11, 2004
Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomasYuji Ueda, Tsuyoshi Itoh, Ikuei Nukaya, et al.
Pageof 1